Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | President, Surgical | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 103,801 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 16,778 · Balance 103,801 F1: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:35 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 16,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000091 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,801 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:16 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 1,008 | $15.08 | $15,200.64 |
DisclosureSEC source: 0001860742-26-000084 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,023 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| May 05, 2026 Filed May 7, 2026 20:35 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 11,970 | $16.00 | $191,520.00 |
DisclosureSEC source: 0001860742-26-000067 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,031 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:01 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 9,221 | $18.30 | $168,744.30 |
DisclosureSEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 3 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,001 F2 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:01 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 4,311 | $18.30 | $78,891.30 |
DisclosureSEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,222 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 23:01 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 4,404 | $18.49 | $81,429.96 |
DisclosureSEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,533 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:26 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 30,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000038 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,937 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:42 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 10,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000013 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,564 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:42 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 6,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020240 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,362 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 22:19 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 2,167 | $14.32 | $31,031.44 |
DisclosureSEC source: 0001127602-25-019670 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,216 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:46 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 968 | $12.33 | $11,935.44 |
DisclosureSEC source: 0001127602-25-017578 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,383 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:22 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 3,029 | $16.00 | $48,464.00 |
DisclosureSEC source: 0001127602-25-007508 · form4.xml · nonDerivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,351 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:22 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 1,110 | $16.00 | $17,760.00 |
DisclosureSEC source: 0001127602-25-007508 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,380 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:30 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 55,793 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007278 · form4.xml · derivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,793 Underlying: Common Shares, No Par Value · 55,793 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:30 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 23,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007278 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,490 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 23:22 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 2,144 | $15.53 | $33,296.32 |
DisclosureSEC source: 0001127602-24-021129 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,067 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:01 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 958 | $15.09 | $14,456.22 |
DisclosureSEC source: 0001127602-24-018923 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,211 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:52 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 1,098 | $16.47 | $18,084.06 |
DisclosureSEC source: 0001127602-24-008215 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,169 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:41 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 50,813 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007903 · form4.xml · derivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,813 Underlying: Common Shares, No Par Value · 50,813 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:41 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 16,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007903 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,267 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:05 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 2,240 | $19.82 | $44,396.80 |
DisclosureSEC source: 0001127602-23-021414 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,489 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 00:13 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 5,361 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015847 · doc4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,729 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which is scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.